These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34345561)

  • 1. Sodium-Glucose Cotransporter-2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis Followed by Excessively Low Carbohydrate Diet.
    Tsutsui E; Hoshina Y; Homma H
    Cureus; 2021 Jul; 13(7):e16085. PubMed ID: 34345561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Euglycemic diabetic ketoacidosis caused by dapagliflozin: A case report.
    Chou YM; Seak CJ; Goh ZNL; Seak JC; Seak CK; Lin CC
    Medicine (Baltimore); 2018 Jun; 97(25):e11056. PubMed ID: 29923997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Normal but Catastrophic" Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report.
    Sarno MJF; Hernandez DPF; Matulac MO
    Cureus; 2023 Nov; 15(11):e49236. PubMed ID: 38143642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Euglycemic diabetic ketoacidosis due to a strict low-carbohydrate diet during treatment with sodium-glucose cotransporter 2 inhibitors.
    Fukuyama Y; Numata K; Yoshino K; Santanda T; Funakoshi H
    Acute Med Surg; 2020; 7(1):e480. PubMed ID: 31988792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk of Euglycemic Diabetic Ketoacidosis Due to Low-carbohydrate Diet While Taking Empagliflozin: a Case Report].
    Yamamoto M; Ide N; Kitajima S; Obayashi M; Asada K; Matsushima S; Ito M
    Yakugaku Zasshi; 2019; 139(11):1479-1483. PubMed ID: 31685745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium-glucose co-transporter-2 inhibitor-associated euglycemic diabetic ketoacidosis that prompted the diagnosis of fulminant type-1 diabetes: A case report.
    Yasuma T; Okano Y; Tanaka S; Nishihama K; Eguchi K; Inoue C; Maki K; Uchida A; Uemura M; Suzuki T; D'Alessandro-Gabazza CN; Gabazza EC; Yano Y
    World J Clin Cases; 2021 May; 9(13):3163-3169. PubMed ID: 33969104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.
    Diaz-Ramos A; Eilbert W; Marquez D
    Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Euglycemic Diabetic Ketoacidosis in the Setting of SGLT2 Inhibitor Use and Hypertriglyceridemia: A Case Report and Review of Literature.
    Gajjar K; Luthra P
    Cureus; 2019 Apr; 11(4):e4384. PubMed ID: 31218148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed euDKA Associated With Dapagliflozin After Pancreatitis.
    Wu G; Wu S; Tang J; Wu H
    Clin Ther; 2023 Jul; 45(7):e167-e170. PubMed ID: 37248092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case Report: Euglycemic Diabetic Ketoacidosis Presenting as Chest Pain in a Patient on a Low Carbohydrate Diet.
    Dorcely B; Nitis J; Schwartzbard A; Newman JD; Goldberg IJ; Sum M
    Curr Diabetes Rev; 2021; 17(2):243-246. PubMed ID: 32178617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUCCESSFUL REIMPLEMENTATION OF A VERY LOW CARBOHYDRATE KETOGENIC DIET AFTER SGLT2 INHIBITOR ASSOCIATED EUGLYCEMIC DIABETIC KETOACIDOSIS.
    Fieger EI; Fadel KM; Modarres AH; Wickham EP; Wolver SE
    AACE Clin Case Rep; 2020; 6(6):e330-e333. PubMed ID: 33244496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin.
    Kelmenson DA; Burr K; Azhar Y; Reynolds P; Baker CA; Rasouli N
    J Investig Med High Impact Case Rep; 2017; 5(2):2324709617712736. PubMed ID: 28634592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors and a Ketogenic Diet: A Case Series and Review of Literature.
    Mistry S; Eschler DC
    AACE Clin Case Rep; 2021; 7(1):17-19. PubMed ID: 33851013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report.
    Alkatheeri A; Alseddeeqi E
    J Med Case Rep; 2022 Mar; 16(1):138. PubMed ID: 35346357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in the Diagnosis of Euglycemic Diabetic Ketoacidosis in a Patient With Multiple Sclerosis Taking a Sodium-Glucose Cotransporter 2 Inhibitor.
    Allison R; Goldstein D; Musso MW
    J Emerg Med; 2019 Jul; 57(1):e1-e3. PubMed ID: 31027990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fall, Fracture, and Two Episodes of Euglycemic Diabetic Ketoacidosis.
    Wasey W; Hutchings S; Dufner A; Okon D; Saleh S
    Cureus; 2022 Jun; 14(6):e25788. PubMed ID: 35812537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrology Consultation for Severe SGLT2 Inhibitor-Induced Ketoacidosis in Type 2 Diabetes: Case Report.
    Nappi F; La Verde A; Carfora G; Garofalo C; Provenzano M; Sasso FC; De Nicola L
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31405158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SGLT-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report and a Literature Review.
    Mahfooz RS; Khan MK; Al Hennawi H; Khedr A
    Cureus; 2022 Jun; 14(6):e26267. PubMed ID: 35911365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: A Case Report.
    Wang KM; Isom RT
    Kidney Med; 2020; 2(2):218-221. PubMed ID: 32734242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis.
    Patel K; Nair A
    Cureus; 2022 Sep; 14(9):e29652. PubMed ID: 36320965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.